| Product Code: ETC12568693 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The long-acting insulin import shipments to Latvia in 2024 show a diverse mix of top exporting countries including Lithuania, Netherlands, Switzerland, Poland, and Germany. With a low Herfindahl-Hirschman Index (HHI) indicating low market concentration, the market remains competitive. The steady Compound Annual Growth Rate (CAGR) of 8.6% from 2020-2024 and a growth rate of 7.03% from 2023-2024 demonstrate a healthy expansion in the demand for long-acting insulin in Latvia. This suggests a promising outlook for the market and potential opportunities for further growth and development.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Long Acting Insulin Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Long Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Long Acting Insulin Market - Industry Life Cycle |
3.4 Latvia Long Acting Insulin Market - Porter's Five Forces |
3.5 Latvia Long Acting Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Long Acting Insulin Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.7 Latvia Long Acting Insulin Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.8 Latvia Long Acting Insulin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Latvia Long Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Latvia |
4.2.2 Rising adoption of long-acting insulin due to its effectiveness |
4.2.3 Growing awareness about diabetes management and treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with long-acting insulin |
4.3.2 Limited access to healthcare facilities in certain regions of Latvia |
4.3.3 Stringent regulatory approval process for new long-acting insulin products |
5 Latvia Long Acting Insulin Market Trends |
6 Latvia Long Acting Insulin Market, By Types |
6.1 Latvia Long Acting Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Long Acting Insulin Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Latvia Long Acting Insulin Market Revenues & Volume, By Lantus, 2021 - 2031F |
6.1.4 Latvia Long Acting Insulin Market Revenues & Volume, By Levemir, 2021 - 2031F |
6.1.5 Latvia Long Acting Insulin Market Revenues & Volume, By Tresiba, 2021 - 2031F |
6.1.6 Latvia Long Acting Insulin Market Revenues & Volume, By Basaglar, 2021 - 2031F |
6.1.7 Latvia Long Acting Insulin Market Revenues & Volume, By Toujeo, 2021 - 2031F |
6.2 Latvia Long Acting Insulin Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Latvia Long Acting Insulin Market Revenues & Volume, By Pen, 2021 - 2031F |
6.2.3 Latvia Long Acting Insulin Market Revenues & Volume, By Syringe, 2021 - 2031F |
6.2.4 Latvia Long Acting Insulin Market Revenues & Volume, By Pump, 2021 - 2031F |
6.2.5 Latvia Long Acting Insulin Market Revenues & Volume, By Pre-filled Device, 2021 - 2031F |
6.3 Latvia Long Acting Insulin Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 Latvia Long Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.3.3 Latvia Long Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.3.4 Latvia Long Acting Insulin Market Revenues & Volume, By Gestational Diabetes, 2021 - 2031F |
6.4 Latvia Long Acting Insulin Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Latvia Long Acting Insulin Market Revenues & Volume, By Solution, 2021 - 2031F |
6.4.3 Latvia Long Acting Insulin Market Revenues & Volume, By Suspension, 2021 - 2031F |
7 Latvia Long Acting Insulin Market Import-Export Trade Statistics |
7.1 Latvia Long Acting Insulin Market Export to Major Countries |
7.2 Latvia Long Acting Insulin Market Imports from Major Countries |
8 Latvia Long Acting Insulin Market Key Performance Indicators |
8.1 Average time taken for regulatory approval of new long-acting insulin products in Latvia |
8.2 Number of diabetes education programs conducted annually |
8.3 Percentage increase in the number of healthcare professionals prescribing long-acting insulin |
8.4 Patient adherence rate to long-acting insulin therapy |
8.5 Rate of hospital admissions due to uncontrolled diabetes despite long-acting insulin usage |
9 Latvia Long Acting Insulin Market - Opportunity Assessment |
9.1 Latvia Long Acting Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Long Acting Insulin Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.3 Latvia Long Acting Insulin Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.4 Latvia Long Acting Insulin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Latvia Long Acting Insulin Market - Competitive Landscape |
10.1 Latvia Long Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Latvia Long Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here